And that’s just the start. We can help you in cloud migration endeavors. Together we can design, transform and build lightweight, API-led, microservices-based architectures using modern digital platforms and continuous integration. We also have expertise in data intelligence and automation including the design, scale and operationalization of unstructured and structured data. And NTT DATA’s Digital Services have been a key to our clients’ success across the globe—and for life sciences companies like yours, will help you step into the future.
There’s no slowing the M&A juggernaut. Life sciences companies
would do well to pay close attention to TSAs and take advantage
of an SI partner early on (during deal-discussion), so they
can assess and plan for the current and future technology
layout and provide the right advice and support.
It’s too important to do it alone.
Click the icon to see how automation is bringing speed and efficiency to clinical trials development processes
Click the icon to learn how to enable a single integrated view of critical real-world data with Analytics as a Service
Click to icon to discover how to architect your data lake for flexibility
Click the icon to understand ways to improve integrated clinical trial management systems through blockchain
Friction is a stumbling block to the success of any business. How can precision medicine – already a special breed in pharma and biotech – benefit from rethinking the supply chain process? Finding the friction requires understanding the process from the view of internal and external customersFIND A BETTER PROCESS
Yes, it can! Imagine a collaborative platform where a patient is prescribed a new medication and then able to communicate with the pharmaceutical provider, discuss side effects in real-time with other users and makes follow up appointments with their provider. But If systems aren’t designed to easily interact with one another or share data with outside platforms, it presents a roadblock.
There’s a major deadline looming: as of November 2018, the U.S Food and Drug Administration is enforcing the Drug Supply Chain Security Act, which requires a product identifier on all prescription drug packaging. This regulation combats drug counterfeiting, which can represent as much as much as 40 percent of supply in some countries. In a survey of over 600 pharma companies, manufacturers, distributors, hospitals, and logistic-providers, only 33 percent were confident they would meet the November 2018 deadline.
Determining your organization’s maturity in digital manufacturing operations takes a structured approach. It starts with assessing capabilities based on agility and capacity to produce and utilize meaningful insights. Our 5C approach addresses connectivity, concurrency, coordination, collaboration and conformity.